Survival of patients with documented autologous recovery after SCT for severe aplastic anemia: A study by the WPSAA of the EBMT

Bone Marrow Transplantation

Volumn 45, Issue 6, 2010, Pages 1008-1013

  Piccin, A ^a,b   McCann, S ^a   Socie G ^c   Oneto, R ^d   Bacigalupo, A ^d   Locasciulli, A ^e   Marsh, J ^f   Schrezenmeier, H ^g   Tichelli, A ^h   Hand, E ^a   Lawler, M ^a   Passweg, J ⁱ  

^a ST JAMES S HOSPITAL   (Ireland)

^b Ospedale San Maurizio   (Italy)

^c Ĥpital Saint Louis ^*  (France)

^d UNIVERSITY OF GENOA   (Italy)

^e SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^f ST GEORGE S HOSPITAL   (United Kingdom)

^g UNIVERSITY HOSPITAL ULM   (Germany)

^h UNIVERSITY HOSPITAL BASEL   (Switzerland)

ⁱ GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

aplastic anemia; autologous recovery; chimerism; HSCT; immunosuppression

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; FLUDARABINE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; DISEASE REGISTRY; DISEASE SEVERITY; EUROPE; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; SCHOOL CHILD; SURVIVAL TIME; T CELL DEPLETION; THERAPY EFFECT; ANEMIA, APLASTIC; GRAFT REJECTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; INFANT; MORTALITY; PANCYTOPENIA; PROCEDURES; REGISTER; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; SURVIVOR; YOUNG ADULT;

ADOLESCENT; ADULT; ANEMIA, APLASTIC; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; GRAFT VS HOST DISEASE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; PANCYTOPENIA; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; SURVIVORS; YOUNG ADULT;

EID: 77954865174     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.296     Document Type: Article

References (19)

1. Camitta BM. Criteria for severe aplastic anaemia. Lancet 1988; 1: 303-304.
2. Young NS. Pathophysiologic mechanisms in acquired aplastic anemia. Hematol Am Soc Hematol Educ Program 2006; 72-77.
3. Marsh JC. Treatment of acquired aplastic anemia. Haematologica 2007; 92: 2-5.
4. Locasciulli A, Oneto R, Bacigalupo A, Socié G, Korthof E, Bekassy A et al. Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplant Group. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 2007; 92: 11-18.
5. McCann SR, Lawler M. Mixed chimaerism; detection and significance following BMT. Bone Marrow Transplant 1993; 11: 91-94.
6. McCann SR, Crampe M, Molloy K, Lawler M. Hemopoietic chimerism following stem cell transplantation. Transfus Apher Sci 2005; 32: 55-61.
7. Hoelle W, Beck JF, Dueckers G, Kreyenberg H, Lang P, Gruhn B et al. Clinical relevance of serial quantitative analysis of hematopoietic chimerism after allogeneic stem cell transplantation in children for severe aplastic anemia. Bone Marrow Transplant 2004; 33: 219-223.
8. Thomas ED, Storb R, Giblett ER, Longpre B, Weiden PL, Fefer A et al. Recovery from aplastic anemia following attempted marrow transplantation. Exp Hematol 1976; 4: 97-102.
9. Rossbach HC, Hosler KM, Chamizo W, Mueller T, Grana NH, Lacson AG et al. Rapid autologous marrow recovery and eradication of infectious mononucleosis despite severe immunosuppression following second transplantation for aplastic anemia. Bone Marrow Transplant 1999; 23: 91-93.
10. Storb R, Weiden PL, Sullivan KM, Appelbaum FR, Beatty P, Buckner CD et al. Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulin. Blood 1987; 70: 116-121.
11. Tichelli A, Schrezenmeier H, Bacigalupo A. Immunosuppressive treatment of aplastic anemiaQ3. In: Schrezenmeier H, Bacigalupo A (eds). Aplastic Anemia: Pathophysiology and Treatment. Cambridge University Press: UK, 2000; ISBN 0 521 64101 2.
12. Lawler M, McCann SR, Marsh JC, Ljungman P, Hows J, Vandenberghe E et al. Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indications for routine assessment of chimerism post SCT for SAA: Severe Aplastic Working Party of the European blood and Marrow Transplant group. Br J Haematol 2009; 144: 933-945.
13. McCann SR, Passweg J, Bacigalupo A, Locasciulli A, Locatelli F, Ryan J et al. The influence of cyclosporin alone, or cyclosporin and methotrexate, on the incidence of mixed haematopoietic chimaerism following allogeneic sibling bone marrow transplantation for severe aplastic anaemia. Bone Marrow Transplant 2007; 39: 109-114.
14. Gowing H, Lawler M, McCann SR, Bacigalupo A. Severe Aplastic Anaemia Working Party of the EBMT. Chimerism studies following allogeneic bone marrow transplantation for severe aplastic anaemia may help predict those patients at higher risk of graft rejection. Exp Hematol 1998; 26: 784-1376
15. Bacigalupo A, Locatelli F, Lanino E, Marsh J, Socié G, Maury S, et al. Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation. Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party. Bone Marrow Transplant 2005; 36: 947-950.
16. Stern M, Passweg JR, Locascuilli A, Socie G, Schrezenmeier H, Bekassy AN et al. Aplastic Anemia Working Party of the European Group for Blood and marrow transplantation. Influence of donor/recipient sex matching on outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia. Transplantation 2006; 82: 218-226.
17. Champlin RE, Perez WS, Passweg JR, Klein JP, Camitta BM, Gluckman E et al. Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens. Blood 2007; 109: 4582-4585.
18. McCann SR, Bacigalupo A, Gluckman E, Hinterberger W, Hows J, Ljungman P et al. Graft rejection and second bone marrow transplants for acquired aplastic anaemia: a report from the Aplastic Anaemia Working Party of the European Bone Marrow Transplant Group. Bone Marrow Transplant 1994; 13: 233-237.
19. Deeg HJ, O'Donnell M, Tolar J, Agarwal R, Harris RE, Feig SA et al. Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood 2006; 108: 1485-1491.